Issue 000 | U.S. Pilot | US

PTPI

Petros Pharmaceuticals, Inc.

Screen state: Passing Source state: Verified 10-Q | 2026-05-13 Filing currency: USD

Open Filing Back to Register Report a correction

Internal NCAV Discount 88.0%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets: 4,394,450USD
Total Liabilities: 2,623,135USD
NCAV: 1,771,315USD
Cash: 4,352,450USD
NCAV per share: 0.04USD/share
Evidence: 6 annual | 25 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Not captured in this issue’s Mary run.

This archived issue is not backfilled with observations from a later screening run.

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: verified

Display basis Normalized to latest verified split basis As reported in each filing

Metric	2026-03-31 10-Q Open filing	2025-12-31 10-K Open filing	2025-09-30 10-Q Open filing	2025-06-30 10-Q Open filing	2025-03-31 10-Q Open filing	2024-12-31 10-K Open filing	2024-09-30 10-Q Open filing	2024-06-30 10-Q Open filing	2024-03-31 10-Q Open filing	2023-12-31 10-K Open filing	2023-09-30 10-Q Open filing	2023-06-30 10-Q Open filing	2023-03-31 10-Q Open filing	2022-12-31 10-K Open filing	2022-09-30 10-Q Open filing	2022-06-30 10-Q Open filing	2022-03-31 10-Q Open filing	2021-12-31 10-K Open filing	2021-09-30 10-Q Open filing	2021-06-30 10-Q Open filing	2020-12-31 10-K Open filing
Period-end Shares Outstanding	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	421,12410,528,103	n/an/a	185,9519,297,538	n/an/a	59,8282,991,377	42,3922,119,620	42,3922,119,620	41,7742,088,698	41,5882,079,387	10,35420,708,024	n/an/a	n/an/a	10,34220,684,723	4,9139,826,599	4,9139,826,599	n/an/a
Weighted-average Basic Shares	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	41,7742,088,698	41,4042,070,210	10,34420,687,284	10,34220,684,723	10,34220,684,723	5,44510,889,766	4,9139,826,599	4,9019,802,309	n/an/a
Weighted-average Diluted Shares	46,222,50246,222,502	28,065,36228,065,362	930,94323,273,564	544,42213,610,547	46,4721,161,791	321,0428,026,038	293,2817,332,030	121,4476,072,349	95,1394,756,952	43,5202,176,017	42,1752,108,747	42,0642,103,220	41,7742,088,698	41,4042,070,210	10,34420,687,284	10,34220,684,723	10,34220,684,723	5,44510,889,766	4,9139,826,599	4,9019,802,309	n/an/a
Basic EPS	-0-0	-2-2	-2-2	-3-3	-9-9	-3-3	-2-2	-2-2	-2-2	-6-6	-4-4	-2-2	-1-1	-10-10	-1-1	-0-0	-0-0	-1-1	-0-0	-0-0	-4-4
Diluted EPS	-0-0	-2-2	-2-2	-3-3	-9-9	-3-3	-2-2	-2-2	-2-2	-6-6	-4-4	-2-2	-1-1	-10-10	-1-1	-0-0	-0-0	-1-1	-0-0	-0-0	-4-4
Basic-to-Diluted Share Difference	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	Insufficient evidence
Net Share Count Change	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	41.1%	0.0%	1.5%	0.4%	301.7%	Insufficient evidence	0.0%	89.9%	110.5%	0.0%	Insufficient evidence	Insufficient evidence
Ownership Claim Change	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	-29.1%	0.0%	-1.5%	-0.4%	-75.1%	Insufficient evidence	0.0%	-47.4%	-52.5%	0.0%	Insufficient evidence	Insufficient evidence

Verified split events: reverse 4.0 on 2022-11-30; reverse 10.0 on 2022-11-30; reverse 2.0 on 2024-10-11; reverse 25.0 on 2026-03-31

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric	2025-12-31 10-K USD	2024-12-31 10-K USD	2023-12-31 10-K USD	2022-12-31 10-K USD	2021-12-31 10-K USD	2020-12-31 10-K USD
Revenue	n/a	5,112,043	5,822,388	5,992,054	7,811,264	9,559,469
Operating Income	-4,641,350	-17,679,650	-13,617,364	-19,915,749	-18,048,016	-17,282,039
Net Income	1,913,595	-14,318,790	-8,163,188	-20,037,573	-8,986,676	-20,585,925
Cash From Operations	-6,734,707	-2,603,051	-7,626,529	-12,797,325	-11,862,031	-15,305,325
Capex	n/a	-24,587	n/a	n/a	-4,633	-4,633
Free Cash Flow	n/a	-2,627,638	n/a	n/a	-11,866,664	-15,309,958
Cash And Equivalents	5,136,722	3,709,971	13,300,000	9,426,264	23,847,572	17,139,694
Accounts Receivable	n/a	416,076	2,226,151	2,110,246	2,455,386	5,152,969
Inventory	n/a	1,349,802	1,610,391	1,815,113	519,649	760,530
Total Current Assets	5,163,598	7,294,278	20,390,396	14,667,905	30,542,695	25,905,053
Total Assets	5,163,598	10,635,310	33,795,795	32,421,214	67,390,058	69,854,014
Total Current Liabilities	2,292,744	18,027,665	10,770,751	7,067,976	30,980,076	41,894,042
Total Liabilities	2,292,744	18,102,888	21,315,772	15,718,747	31,845,094	52,384,962
Shareholders Equity	2,870,854	-7,467,578	12,071,041	16,702,467	35,544,964	17,469,052
Shares Outstanding	42,284,502	10,528,103	2,991,377	2,079,387	20,684,723	9,707,655
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	28,065,362	8,026,038	2,176,017	2,070,210	10,889,766	5,340,682
Weighted Avg Shares Basic	28,065,362	8,026,038	2,176,017	2,070,210	10,889,766	5,340,682
Net Share Count Change (Normalized)	Insufficient evidence	Insufficient evidence	41.1%	301.7%	110.5%	Insufficient evidence
Ownership Claim Change (Normalized)	Insufficient evidence	Insufficient evidence	-29.1%	-75.1%	-52.5%	Insufficient evidence

Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric	2026-03-31 10-Q USD	2025-12-31 10-K USD	2025-12-31 10-K USD	2025-09-30 10-Q USD	2025-06-30 10-Q USD	2025-03-31 10-Q USD	2024-12-31 10-K USD	2024-12-31 10-K USD	2024-09-30 10-Q USD	2024-06-30 10-Q USD	2024-03-31 10-Q USD	2023-12-31 10-K USD	2023-12-31 10-K USD	2023-09-30 10-Q USD	2023-06-30 10-Q USD	2023-03-31 10-Q USD	2022-12-31 10-K USD	2022-12-31 10-K USD	2022-09-30 10-Q USD	2022-06-30 10-Q USD	2022-03-31 10-Q USD	2021-12-31 10-K USD	2021-12-31 10-K USD	2021-09-30 10-Q USD	2021-06-30 10-Q USD
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	725,403	725,400	1,576,366	1,421,471	1,388,806	-364,250	-364,250	1,674,657	1,994,011	2,517,972	798,101	798,101	-1,457,732	4,186,516	2,465,169	-867,160	-867,160	2,145,169	2,457,649
Operating Income	-1,027,179	-391,486	-391,486	-990,737	-1,800,778	-1,458,349	-9,130,722	-9,130,724	-2,339,748	-2,280,905	-3,928,273	-5,038,618	-5,038,618	-4,806,641	-2,462,808	-1,309,297	-4,101,112	-4,101,113	-13,672,018	-1,661,420	-481,198	-7,973,200	-7,973,200	-3,596,617	-4,280,692
Net Income	-987,036	-5,769,352	-336,506	-922,723	5,432,846	-2,260,022	-9,273,440	-9,273,440	-2,220,661	-662,026	-2,162,663	318,150	318,150	-4,549,508	-2,546,683	-1,385,147	-4,221,360	-4,221,361	-13,830,196	-1,811,792	-174,224	-8,185,942	-8,185,942	-1,696,898	-2,112,917
Cash From Operations	-784,272	-933,544	-933,544	-1,133,924	-3,007,151	-1,660,088	965,405	965,405	-771,246	-1,662,362	-1,134,848	-2,259,894	-2,259,894	-4,046,202	-572,070	-748,363	-1,570,340	-1,570,340	-1,751,476	-4,199,808	-5,275,701	-8,304,299	-8,304,299	-1,211,366	-1,899,785
Capex	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Free Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash And Equivalents	4,352,450	5,136,722	5,136,722	6,070,266	7,321,501	8,931,054	3,709,971	3,709,971	3,900,000	7,500,000	11,100,000	13,300,000	13,300,000	18,000,000	7,400,000	8,300,000	9,426,264	9,426,264	11,200,000	13,295,089	17,671,871	23,847,572	23,847,572	8,135,184	11,031,177
Total Current Assets	4,394,450	5,163,598	5,163,598	6,133,468	7,396,843	14,465,646	7,294,278	7,294,278	10,724,480	13,979,045	17,902,455	20,390,396	20,390,396	24,433,180	13,150,892	13,903,466	14,667,905	14,667,905	18,771,620	22,853,237	26,838,105	30,542,695	30,542,695	13,354,324	16,234,052
Total Liabilities	2,623,135	2,292,744	2,292,744	2,765,381	2,949,960	27,189,574	18,102,888	18,102,888	17,576,521	15,983,229	19,618,777	21,315,772	21,315,772	31,857,093	15,782,819	15,122,772	15,718,747	15,718,747	17,001,461	16,832,900	20,137,579	31,845,094	31,845,094	34,188,332	37,179,517
Shares Outstanding	42,372,502	42,284,502	42,284,502	42,284,502	42,284,502	2,052,762	10,528,103	10,528,103	10,014,872	9,297,538	6,881,864	2,991,377	2,991,377	2,119,620	2,119,620	2,088,698	2,079,387	2,079,387	20,708,024	20,684,723	20,684,723	20,684,723	20,684,723	9,826,599	9,826,599
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	46,222,502	28,065,362	42,284,500	42,284,502	25,922,503	1,161,791	8,026,038	10,086,832	9,829,793	7,388,107	4,756,952	2,176,017	2,375,636	2,119,620	2,117,581	2,088,698	2,070,210	2,070,210	20,692,321	20,684,723	20,684,723	10,889,766	14,140,539	9,826,599	9,802,309
Weighted Avg Shares Basic	46,222,502	28,065,362	42,284,500	42,284,502	25,922,503	1,161,791	8,026,038	10,086,832	9,829,793	7,388,107	4,756,952	2,176,017	2,375,636	2,119,620	2,117,581	2,088,698	2,070,210	2,070,210	20,692,321	20,684,723	20,684,723	10,889,766	14,140,539	9,826,599	9,802,309
Net Share Count Change (Normalized)	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	41.1%	41.1%	0.0%	1.5%	0.4%	301.7%	301.7%	Insufficient evidence	0.0%	89.9%	110.5%	110.5%	0.0%	Insufficient evidence
Ownership Claim Change (Normalized)	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	-29.1%	-29.1%	0.0%	-1.5%	-0.4%	-75.1%	-75.1%	Insufficient evidence	0.0%	-47.4%	-52.5%	-52.5%	0.0%	Insufficient evidence

Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input	Value	Source concept	Filing period	Confidence	Provenance
Current Assets	4,394,450USD	us-gaap:AssetsCurrent	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001815903/companyfacts.json Data Vault \| sec/companyfacts/cik=0001815903/companyfacts.json
Total Liabilities	2,623,135USD	us-gaap:Liabilities	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001815903/companyfacts.json Data Vault \| sec/companyfacts/cik=0001815903/companyfacts.json
Cash	4,352,450USD	us-gaap:CashAndCashEquivalentsAtCarryingValue	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001815903/companyfacts.json Data Vault \| sec/companyfacts/cik=0001815903/companyfacts.json
Shares Outstanding	42,372,502	us-gaap:CommonStockSharesOutstanding	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001815903/companyfacts.json Data Vault \| sec/companyfacts/cik=0001815903/companyfacts.json
NCAV	1,771,315USD	derived	2026-03-31	n/a	company-evidence-v1 \| total_current_assets - total_liabilities
NCAV per share	0.04USD	derived	2026-03-31	n/a	company-evidence-v1 \| NCAV / shares_outstanding
Internal NCAV Discount	88.0%	derived	2026-03-31	n/a	gnni_publication_pack \| internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source: Data Vault
Data Vault Root: Local evidence | The Data Vault
CIK: 0001815903
Company ID: n/a
Selected Annual Source: Data Vault | sec/companyfacts/cik=0001815903/companyfacts.json
Selected Quarterly Source: Data Vault | sec/companyfacts/cik=0001815903/companyfacts.json
Statement Extractor: companyfacts-screener-v1
View Extractor: companyfacts-screener-v1
Source Accession Count: 21
Imported At: 2026-08-15T12:52:41+00:00
Rendered At: 2026-08-16T03:29:34+00:00

Run Audit

Mary Run: 1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of: 2026-07-03
Accession: 0001104659-26-060359
CIK: 0001815903
Mary Filing Date: 2026-05-13
Filing Currency: USD
Internal Discount: 88.0%
Source State: Verified
Market Context: Not Displayed
Market Policy: internal_only_not_redistributed
Share Trend: Not Evaluated
Dilution: Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-13; mary_accession=0001104659-26-060359; mary_cik=0001815903; gnni_supporting_filing_date=2026-05-13; internal_discount=0.880393; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive